MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
MapLight Therapeutics has raised $150.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2026.
MapLight Therapeutics's investors include Sanofi, Blue Owl, Novo Holdings, Michael J. Fox Foundation, T. Rowe Price.
MapLight Therapeutics is headquartered in Palo Alto, United States.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
MapLight Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MapLight Therapeutics — Funding & Investors." VCBacked, August 13, 2026, https://www.vcbacked.co/company/maplight-therapeutics. Accessed September 21, 2026.
VCBacked. (2026). MapLight Therapeutics — Funding & Investors. Retrieved September 21, 2026, from https://www.vcbacked.co/company/maplight-therapeutics
{{cite web |title=MapLight Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/maplight-therapeutics |website=VCBacked |access-date=September 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated